Inogen, Inc. (FRA:6IO)

Market Cap	146.32M -19.6%
Revenue (ttm)	296.96M +3.9%
Net Income	-19.37M
EPS	-0.73
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	5.60
Previous Close	5.45
Day's Range	5.60 - 5.60
52-Week Range	4.50 - 7.65
Beta	n/a
RSI	61.15
Earnings Date	May 6, 2026

About Inogen

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airw...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2001
• Employees: 753
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 6IO

Financial Performance

In 2025, Inogen's revenue was $348.67 million, an increase of 3.86% compared to the previous year's $335.71 million. Losses were -$22.75 million, -36.62% less than in 2024.

Financial numbers in USD